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   Thyroid hormones regulate the metabolisms of all cells including hepatocytes, and hence, modulate 
hepatic function. Hyperthyroidism is one of the most common endocrine disorders characterized by 
increased secretion of thyroid hormones T3 and/or T4. This study investigated frequency of abnormal 
liver function tests in the patients with hyperthyroidism that referred to Imam Reza Hospital of 
Kermanshah from 1
st
 October 2009 to 30
th
 April 2012. Patients who had complication disorders such as 
cardiovascular disease, hypertension, diabetes mellitus, liver disease and using any of drugs effecting 
liver and thyroid function tests and patients with positive hepatic viral markers were excluded from the 
study. After excluding patients with complication disorders, fifty patients were remained. Fifty 
volunteers without history of significant diseases were chosen as matched control group. Mean ALT 
(Alanine amino transferase) of cases were 52.1±6.97 and of controls were 25.6±3.9. Also, Mean ALP 
(Alkaline phosphatase) of cases was 259.94±25.83 and of controls were 185.10±33.75. There is 
significant difference between ALT, ALP in case group in compare the control group (P<0.05and 
P<0.01 respectively). Further, there is no significant difference in serum levels of AST (Aspartate amino 
transferase) and Mean direct bilirubin between case and control group. These findings indicate that ALT 
and ALP levels are frequently elevated in hyperthyroidism. Hence, they are possibly thyroid dependent 
enzymes. 
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INTRODUCTION 
   Hyperthyroidism is a relatively common 
disease in which tissues are stimulated by an 
increased secretion of thyroid hormones 
tiroiodothyronin (T3) and/or thyroxin (T4) (1). 
T3 is the biologically active thyroid hormone. 
These hormones are required for the normal 
growth, development and function of nearly all 
tissues (2).Thyroid hormones are metabolized 
within the liver and subsequently excreted into 
the bile. Increased metabolism in response to 
hyperthyroidism can cause oxidative damage to 
certain organs including the cardiovascular, 
nervous, gastrointestinal, and hepatic systems 
(3).Therefore it is not surprising that hepatic 
dysfunction is commonly observed in patients 
with hyperthyroidism. The pathogenesis of  
 
hepatic disorders in hyperthyroidism is 
unknown. Liver function tests (LFT) including 
Alanine amino transferase (ALT), Aspartate 
amino transferase (AST), Alkaline phosphatase 
(ALP) and direct bilirubin (DBIL) are the best 
way for evaluation of liver function (4). There is 
no enough study about hepatic dysfunction in 
hyperthyroidism. Obtaining information about 
hepatic dysfunction in hyperthyroidism can help 
to physician for understanding about non-cause 
and illusory of liver dysfunction.    
The aim of this study was to evaluate the liver 
function in hyperthyroidism patients refer to 
Imam Reza Hospital of Kermanshah University 
of Medical Sciences.  
 
 




MATERIALS AND METHODS 
 The study was conducted on 50 subjects of age 
group 23 to 65 years old who had been 
diagnosed with hyperthyroidism between 
October 2009 to April 2012. Patients who had 
complications such as cardiovascular disease, 
hypertension and diabetes mellitus were 
excluded from the study. The patients who have 
the history of liver disease and using any of 
drugs effecting liver and thyroid function tests 
and patients with positive hepatic viral markers 
were excluded from the study. 50 healthy 
subjects free from hyperthyroidism aged 25 to 
65 years were used as control. In all subjects, 
after 12h fasting period, 5ml venous blood 
sample was collected. The samples were spun in 
a Centrifuge at 1000g for 5 minutes. Serum 
obtained after centrifugation was divided into2 
aliquots, one for liver function tests and second 
for thyroid function tests. Sample for ALT, 
AST, ALP and DBIL was analyzed 
immediately. Aliquots for thyroid function tests 
were stored at -70oC until batch analysis. Liver 
Function Tests (DBIL, ALT, AST and ALP) 
were assayed by the calorimetric method using 
standard reagent kits (pars azmoom,iran).Serum 
T3, T4and TSH measurements were performed 
by using Enzyme linked immunosorbent 
assay(ELISA) kits (monobind,USA). Results 
are expressed as the mean ± standard deviation. 
The statistical evaluation of data was performed 
by student t-test. P < 0.05 was considered 
statistically significant. Statistical analysis was 
carried out using SPSS for windows 16.0 
software. Age group 23 to 65 years old who had 
been diagnosed with hyperthyroidism between 
October 2009 to April 2012. Patients who had 
complications such as cardiovascular disease, 
hypertension and diabetes mellitus were 
excluded from the study. The patients who have 
the history of liver disease and using any of 
drugs effecting liver and thyroid function tests 
and patients with positive hepatic viral markers 
were excluded from the study. 50 healthy 
subjects free from hyperthyroidism aged 25 to 
65 years were used as control. In all subjects, 
after 12h fasting period, 5ml venous blood 
sample was collected. The samples were spun in 
a Centrifuge at 1000g for 5 minutes. Serum 
obtained after centrifugation was divided into2 
aliquots, one for liver function tests and second 
for thyroid function tests. Sample for ALT, 
AST, ALP and DBIL was analyzed 
immediately. Aliquots for thyroid function tests 
were stored at -70oC until batch analysis. Liver 
Function Tests (DBIL, ALT, AST and ALP) 
were assayed by the calorimetric method using 
standard reagent kits (pars azmoom,iran).Serum 
T3, T4and TSH measurements were performed 
by using Enzyme linked immunosorbent 
assay(ELISA) kits(monobind,USA). Results are 
expressed as the mean ± standard deviation. The 
statistical evaluation of data was performed by 
student t-test. P<0.05 was considered 
statistically significant. Statistical analysis was 




   The mean age of 50 hyperthyroid cases and 50 
controls were 45.08±17.38 and 46.11±16.83 
years, respectively.  Mean age of males and 
females in hyperthyroid cases were 43.1±5.42 
and 43±5.89 years respectively. And of controls 
were 42.32±7.81 and 43.03±6.35 years 
respectively. The cases and controls did not 
differ significantly with respect to age and 
gender. Table 1 shows mean thyroid hormone 
concentration in cases and controls. Table 2 
shows the mean serum concentration of DBIL, 
ALP, AST and ALT of the controls and 
hyperthyroid cases. The serum levels of AST 
and ALP in hyperthyroid cases were 
significantly increased when compared with 
controls (P< 0.05). The levels of ALT and 
DBIL in hyperthyroid cases were not 
significantly differ from controls (P>0.05).
 





T3 3.80±0.71 1.13±0.33 
T4 18.66±2.20 7.89±1.93 


















DBIL 0.59±0.10 0.23±0.07 NS 
ALP 259.94±25.83 185.10±33.75 P<0.01 
ALT 52.1±6.97 25.6±3.9 P<0.05 
AST 38.12±7.2 23.78±4.67 NS 




 Thyroid hormones modulate the functions of 
body organs, tissues and cells (5). The liver is 
generally affected in thyroid function (6). 
Assessment of thyroid in liver disease should be 
accompanied with laboratory measurement of 
thyroid hormones (7). The laboratory procedure 
based on the measurement of T3, T4 and 
thyroid stimulating hormone (TSH) and others 
related thyroid parameters at the first step of 
laboratory investigations. In fact, laboratory 
measurements are suggested not only for 
hepatic dysfunction but also in other various 
abnormalities (8). Many liver function test 
elevation, have been reported in 
hyperthyroidism. These could be listed as 
increase in DBIL, ALT, AST and ALP (9, 10). 
The mechanism of this elevation appears to be 
relative hypoxia in periventricular regions of the 
liver (11). Upadhyay et al. (12) show that 
elevated levels of T3 induces apoptosis of 
hepatocytes and causes hepatic dysfunction 
through the activation of the mitochondrial 
dependent pathway. In the present study 50 
hyperthyroid cases and 50 matched controls 
were selected and examined for their serum 
levels of enzymes AST, ALT, ALP and DBIL. 
The results of this study showed that ALP and 
ALT level was elevated in cases when 
compared with the control. In hepatic injury an 
increase in levels of AST and ALT was reported 
in 27% and 37% of the patients respectively 
(13). Out of the 50 cases, 19 (38%) had at least 
one abnormal result of a liver function test and 
ALP is the most commonly elevated enzyme 
among them (16, 32%). These findings indicate 
that abnormal results of liver function tests are 
common in patients with hyperthyroidism.  
Biscoveanu et al. (6) reports of the 30 study 
patients, 11 (37%) had at least one abnormal 
result of a liver function test. All 30 patients in 
his study had determinations of AP (not 
fractionated), of which 10 values (33%) were 
above normal (range, 124 to 283 U/L). Of the 
30 patients who had determinations of AST, 5 
(17%) had increased values that ranged from 36 
to 71 U/L. Six of the 23 patients (26%) with 
determinations of ALT had increased values 
that ranged from 45 to 157 U/L. In addition, 2 
of the 24 patients (8%) with determinations of 
total bilirubin had increased levels. Further, our 
results are in according to Nobakht and 
Aydemirstudies studies (2, 14). The increased 
osteoblastic activity is pointed out as a cause of 
elevated ALP in patients with hyperthyroidism 
(15). Although liver enzymes levels were 
elevated in many hyperthyroid cases, no 
significant correlation emerged between the 
thyroid hormones and AST and DBIL, either in 
cases or controls probably because of small 
sample size. The study showed that prevalence 
of hyperthyroidism is higher in females than in 
males, but its etiology is unknown. With respect 
to it was mentioned in this present study, for 
preventing any mistreatment it is recommended 
that thyroid laboratory investigation for the 
thyroid gland should be done before any liver 
treatment.   
 
CONCLUSION  
   In summary, Based on the results obtained 
from this study, suggest that hyperthyroidism is 
often associated with abnormal hepatocellular 
enzymes particularly ALT and ALP elevation 
and thus can be used as a diagnostic tool for 
predicting the presence of clinically significant 
hepatic changes in patients with 
hyperthyroidism. Also, our results show that 
make the diagnosis of concomitant, unrelated 
liver disease difficult until the euthyroid state 
has been established. Our results can help to 
physician for understanding about non-cause 
and illusory of liver dysfunction. We propose 
more study with more cases to determine clearly 
results about liver dysfunction in 
hyperthyroidism.   
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